Clinical Trial Update: Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and tolerability of an intravenously administered cancer vaccine in patients with advanced melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Cancer vaccine (BioNTech)

Snippet

Sponsor: BioNTech SE | Conditions: Melanoma | Phase 1 | Status: COMPLETED